bioRxivBiochemistryPreprint
Reduced protein kinase C delta association with a higher molecular weight complex in mitochondria of Barth Syndrome lymphoblasts
Abstract
The protein kinase C delta (PKC{delta}) signalosome exists as a high molecular weight complex in mitochondria and controls mitochondrial oxidative phosphorylation. Barth Syndrome (BTHS) is a rare X-linked genetic disease in which mitochondrial oxidative phosphorylation is impaired due to a mutation in the gene TAFAZZIN which results in reduction in the phospholipid cardiolipin and an accumulation of monolysocardiolipin. Here we examined if PKC{delta} association with a higher molecular weight complex was altered in mitochondria of BTHS lymphoblasts. Immunoblot analysis of blue native-polyacrylamide gel electrophoresis mitochondrial fractions revealed that PKC{delta} associated with a higher molecular weight complex in control lymphoblasts but this was markedly reduced in BTHS patient B lymphoblasts in spite of an increase in PKC{delta} protein expression. We hypothesize that the lack of PKC{delta} within this higher molecular weight complex may contribute to defective mitochondrial PKC{delta} signaling and thus to the bioenergetic defects observed in BTHS.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Barth syndrome cellular models have dysregulated respiratory chain complex I and mitochondrial quality control due to abnormal cardiolipin
Arianna Franca Anzmann, Olivia Sniezek Carney, … Hilary J. Vernon·bioRxiv·Jan 6, 2021
- Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth Syndrome
Olivia Sniezek Carney, Kodi William Harris, … Hilary J. Vernon·Human Molecular GeneticsPeer-reviewed·Oct 29, 2024
- Deficient Cardiolipin Remodeling Alters Muscle Fiber Composition and Neuromuscular Connectivity in Barth Syndrome
Catalina Matias, Paige L. Snider, … Jeffrey J. Brault·bioRxiv·Oct 31, 2025
- Targeting ALCAT1 Ameliorates Cardiomyopathy in Barth Syndrome
Jun Zhang, Qianqian Ye, … Yuguang Shi·bioRxiv·Sep 28, 2026
- An unexpected lack of difference in superoxide/H2O2 production rates in isolated heart and skeletal muscle mitochondria from a mouse model of Barth Syndrome
R. L. S. Goncalves, M. Schlame, … G. S. Hotamisligil·bioRxiv·May 7, 2020
- Upregulation of the AMPK-FOXO1-PDK4 pathway is a primary mechanism of pyruvate dehydrogenase activity reduction and leads to increased glucose uptake in tafazzin-deficient cells
Z. Liang, T. Ralph-Epps, … M. Greenberg·bioRxiv·Feb 3, 2024